CAMP 8-K 2026-07-27

Camp4 Therapeutics Corp (CAMP) 8-K dated 2026-07-27 — accession 0001628280-26-049661. This URL is the filing, not the CAMP hub.

Camp4 Therapeutics Corp (CAMP) is a biotechnology company listed on NASDAQ.

Camp4 Therapeutics Corp filed a 8-K on 2026-07-27. Accession 0001628280-26-049661.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CAMP revenue for 2025-12-31 was $3.5M. Net income was -$80.4M. Revenue was up 436.5% from 2024-12-31 to 2025-12-31. CAMP currently screens at market cap $215.0M.

Not investment advice. The CAMP SEC hub lists recent forms. The stock page is the research view.